Literature DB >> 12603680

Cyclosporin: applications in small animal dermatology.

David C Robson1, Gregory G Burton.   

Abstract

Cyclosporin has been increasingly used for the treatment of skin diseases in small animals. Reported uses include the treatment of atopy, cutaneous lupus erythematosus, feline acquired alopecia resembling pseudopelade of humans, pemphigus erythematosus, pemphigus foliaceus, perianal fistulae and sebaceous adenitis. In addition, cyclosporin has been used anecdotally for several other skin diseases. Few side effects have been noted at doses therapeutic for dermatologic diseases. Current suggestions for monitoring, and the value of trough cyclosporin serum concentrations for prediction of toxicity and efficacy are discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12603680     DOI: 10.1046/j.1365-3164.2003.00317.x

Source DB:  PubMed          Journal:  Vet Dermatol        ISSN: 0959-4493            Impact factor:   1.589


  4 in total

1.  Cyclosporine treatment of perianal gland adenoma concurrent with benign prostatic hyperplasia in a dog.

Authors:  Chul Park; Jong-Hyun Yoo; Ha-Jung Kim; Chae-Young Lim; Ju-Won Kim; So-Young Lee; Jung-Hyun Kim; Jae-Im Jang; Hee-Myung Park
Journal:  Can Vet J       Date:  2010-11       Impact factor: 1.008

Review 2.  Life-long diseases need life-long treatment: long-term safety of ciclosporin in canine atopic dermatitis.

Authors:  Tim Nuttall; Douglas Reece; Elizabeth Roberts
Journal:  Vet Rec       Date:  2014-03       Impact factor: 2.695

3.  A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs.

Authors:  Peter R Little; Vickie L King; Kylie R Davis; Sallie B Cosgrove; Michael R Stegemann
Journal:  Vet Dermatol       Date:  2014-12-12       Impact factor: 1.589

4.  Dose tapering for ciclosporin in cats with nonflea-induced hypersensitivity dermatitis.

Authors:  Jean Steffan; Elizabeth Roberts; Andrea Cannon; Pascal Prélaud; Peter Forsythe; Jacques Fontaine; Stephen King; Wolfgang Seewald
Journal:  Vet Dermatol       Date:  2013-03-27       Impact factor: 1.589

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.